172 related articles for article (PubMed ID: 3574856)
1. Secondary involvement of the central nervous system in malignant non-Hodgkin's lymphoma. A study of 30 cases in a series of 498 patients.
Hoerni-Simon G; Suchaud JP; Eghbali H; Coindre JM; Hoerni B
Oncology; 1987; 44(2):98-101. PubMed ID: 3574856
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin's Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease.
Huang S; Jin L; Yang J; Duan Y; Zhang M; Zhou C; Zhang YH
Technol Cancer Res Treat; 2021; 20():15330338211016372. PubMed ID: 34060372
[TBL] [Abstract][Full Text] [Related]
3. Autologous bone marrow transplantation for patients with non-Hodgkin's lymphoma and CNS involvement: those transplanted with active CNS disease have a poor outcome--a report by the European Bone Marrow Transplant Lymphoma Registry.
Williams CD; Pearce R; Taghipour G; Green ES; Philip T; Goldstone AH
J Clin Oncol; 1994 Nov; 12(11):2415-22. PubMed ID: 7964958
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the central nervous system in non-Hodgkin's lymphoma.
Cetto GL; Iannucci A; Tummarello D; Rizzuto N; Sabbioni R; Menestrina F
Tumori; 1981 Feb; 67(1):39-44. PubMed ID: 7245353
[TBL] [Abstract][Full Text] [Related]
5. CNS involvement in children with newly diagnosed non-Hodgkin's lymphoma.
Sandlund JT; Murphy SB; Santana VM; Behm F; Jones D; Berard CW; Furman WL; Ribeiro R; Crist WM; Greenwald C; Chen G; Walter A; Pui CH
J Clin Oncol; 2000 Aug; 18(16):3018-24. PubMed ID: 10944136
[TBL] [Abstract][Full Text] [Related]
6. The incidence of secondary central nervous system involvement in patients with non-Hodgkin's lymphoma as detected by 18F-FDG PET/CT.
Akkas BE; Vural GU
Nucl Med Commun; 2013 Jan; 34(1):50-6. PubMed ID: 23111376
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
Sakarou M; Eisele L; Dührsen U; Hüttmann A
Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
[TBL] [Abstract][Full Text] [Related]
8. Central nervous system involvement following diagnosis of non-Hodgkin's lymphoma: a risk model.
Hollender A; Kvaloy S; Nome O; Skovlund E; Lote K; Holte H
Ann Oncol; 2002 Jul; 13(7):1099-107. PubMed ID: 12176790
[TBL] [Abstract][Full Text] [Related]
9. Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis.
Recht L; Straus DJ; Cirrincione C; Thaler HT; Posner JB
Am J Med; 1988 Mar; 84(3 Pt 1):425-35. PubMed ID: 3348245
[TBL] [Abstract][Full Text] [Related]
10. [Involvement of the central nervous system in generalized non-Hodgkin's lymphomas (author's transl)].
Gerlach H; Jänisch W; Schreiber D; Feist H; Wessel H
Arch Geschwulstforsch; 1980; 50(1):1-10. PubMed ID: 7447626
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal chemotherapy alone is inadequate central nervous system prophylaxis in patients with intermediate-grade non-Hodgkin's lymphoma.
Chua SL; Seymour JF; Streater J; Wolf MM; Januszewicz EH; Prince HM
Leuk Lymphoma; 2002 Sep; 43(9):1783-8. PubMed ID: 12685832
[TBL] [Abstract][Full Text] [Related]
12. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
13. Involvement of the central nervous system by non-Hodgkin's lymphoma in adults. A review of 36 cases.
Mead GM; Kennedy P; Smith JL; Thompson J; Macbeth FR; Ryall RD; Williams CJ; Whitehouse JM
Q J Med; 1986 Jul; 60(231):699-714. PubMed ID: 3763820
[TBL] [Abstract][Full Text] [Related]
14. Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors.
Liang R; Chiu E; Loke SL
Hematol Oncol; 1990; 8(3):141-5. PubMed ID: 2373491
[TBL] [Abstract][Full Text] [Related]
15. [Central nervous system involvement in non-Hodgkin's lymphoma].
Nishikori M; Sorachi K; Doi S; Arita Y; Kamesaki H; Ohno H; Kita K; Fukuhara S; Uchino H; Yamabe H
Rinsho Ketsueki; 1986 Nov; 27(11):2051-8. PubMed ID: 3820624
[No Abstract] [Full Text] [Related]
16. Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non-hodgkin lymphoma.
Tomita N; Kodama F; Kanamori H; Motomura S; Ishigatsubo Y
Cancer; 2002 Aug; 95(3):576-80. PubMed ID: 12209750
[TBL] [Abstract][Full Text] [Related]
17. Non-Hodgkin's lymphoma of the central nervous system after treatment of Hodgkin's disease.
Miller DC; Knee R; Schoenfeld S; Wasserstrom WR; Karp G
Am J Clin Pathol; 1989 Apr; 91(4):481-5. PubMed ID: 2929506
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. Nebraska Lymphoma Study Group.
Conlan MG; Bast M; Armitage JO; Weisenburger DD
J Clin Oncol; 1990 Jul; 8(7):1163-72. PubMed ID: 1694234
[TBL] [Abstract][Full Text] [Related]
19. Central nervous system relapse in unfavourable-histology non-Hodgkin's lymphoma: is prophylaxis indicated?
Johnson GJ; Oken MM; Anderson JR; O'Connell MJ; Glick JH
Lancet; 1984 Sep; 2(8404):685-7. PubMed ID: 6147703
[TBL] [Abstract][Full Text] [Related]
20. CNS involvement in the non-Hodgkin's lymphomas.
Levitt LJ; Dawson DM; Rosenthal DS; Moloney WC
Cancer; 1980 Feb; 45(3):545-52. PubMed ID: 6986199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
